Evolus (EOLS) - News Mentions

Sign up to add (EOLS) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Johnson & Johnson
Johnson & Johnson
JNJ		 0 100%
Eli Lilly and Company
Eli Lilly and Company
LLY		 1 0%
Pfizer
Pfizer
PFE		 6 50%
Astrazeneca
Astrazeneca
AZN		 4 0%
AbbVie
AbbVie
ABBV		 1 0%
Short Interest in Evolus, Inc. (NASDAQ:EOLS) Grows By 8.8%
November 19
Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher
November 17
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Los Angeles Capital Management LLC
November 15
Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS)
November 13
Creative Planning Has $250,000 Stake in Evolus, Inc. (NASDAQ:EOLS)
November 11
Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
November 8
Evolus Third Quarter 2024 Earnings: Misses Expectations
November 7
Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges
November 6
Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates
November 6
Evolus Reports Third Quarter 2024 Results
November 6
Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript
November 6
Evolus : Investor Presentation
November 6
Evolus : Reports Third Quarter 2024 Results Form 8 K
November 6
Evolus to Participate in Stifel 2024 Healthcare Conference
November 3
Evolus Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels under New Medical Device Regulation
October 31
Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
October 31

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Evolus mentioned in the news?

Evolus was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Evolus performing compared to its industry peers?

Evolus underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Evolus in the last month?

There has been no significant change in the number of news mentions for Evolus' compared to the last month.

Why is it important to track news mentions for Evolus?

By monitoring mentions in the news for Evolus, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Evolus, ultimately improving their investment strategies.

Sign up and get more insights on Evolus.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact